{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:20:04Z","timestamp":1791566404829,"version":"4.3.4"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.radonc.2025.110822","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:21:35Z","timestamp":1740223295000},"page":"110822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Rationale, implementation considerations, delineation and planning target objective recommendations for volumetric modulated arc therapy and helical tomotherapy total body irradiation, total marrow irradiation, total marrow and lymphoid irradiation and total lymphoid irradiation"],"prefix":"10.1016","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3026-8721","authenticated-orcid":false,"given":"Bianca A.W.","family":"Hoeben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Saldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Engellau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrahams","family":"Ocanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Hiniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Misson-Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria A.","family":"Kobyzeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"George Mikhaeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rodriguez-Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Seravalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam E.","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Losert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per E.","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.L.","family":"Fulcheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Zucchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Loginova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharine H.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Y.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110822_b0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0010","article-title":"Considerations for intensity modulated total body or total marrow and lymphoid irradiation","volume":"43","author":"Parsons","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmp.2019.03.032","article-title":"Implementing safe and robust Total Marrow Irradiation using Helical Tomotherapy - a practical guide","volume":"60","author":"Haraldsson","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2025.110822_b0020","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220650","article-title":"Optimised conformal total body irradiation: a heterogeneous practice, so where next?","volume":"96","author":"Misson-Yates","year":"2023","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.110822_b0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.prro.2021.12.007","article-title":"The Stanford volumetric modulated arc therapy total body irradiation technique","volume":"12","author":"Kovalchuk","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0030","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30589","article-title":"Improved organ sparing using auto-planned Stanford volumetric modulated arc therapy for total body irradiation technique","volume":"70","author":"Ngo","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2025.110822_b0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.prro.2021.02.010","article-title":"A step toward making VMAT TBI more prevalent: automating the treatment planning process","volume":"11","author":"Simiele","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2014.09.014","article-title":"Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation","volume":"91","author":"Takahashi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110366","article-title":"Technical recommendations for implementation of volumetric modulated arc therapy and helical tomotherapy total body irradiation","volume":"197","author":"Seravalli","year":"2024","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0050","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1118\/1.3495816","article-title":"Statistical analysis of dose heterogeneity in circulating blood: implications for sequential methods of total body irradiation","volume":"37","author":"Molloy","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0055","doi-asserted-by":"crossref","unstructured":"Guo B, Sheen C, Murphy E, Xia P. Dose to Circulating Blood in Intensity-Modulated Total Body Irradiation, Total Marrow Irradiation, and Total Marrow and Lymphoid Irradiation Using Realistic Whole-Body Blood Circulation Modeling. AAPM 66th annual meeting and exhibition. 2024.","DOI":"10.1002\/mp.17913"},{"key":"10.1016\/j.radonc.2025.110822_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1044539","article-title":"Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy","volume":"12","author":"Ladbury","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29689","article-title":"Volumetric modulated arc therapy total body irradiation in pediatric and adolescent\/young adult patients undergoing stem cell transplantation: early outcomes and toxicities","volume":"69","author":"Marquez","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2025.110822_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1459287","article-title":"Volumetric modulated arc therapy total body irradiation improves toxicity outcomes compared to 2D total body irradiation","volume":"14","author":"Hui","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0075","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0360-3016(80)90241-2","article-title":"Total Body Irradiation Conference: discussion: the radiobiological bases of TBI","volume":"6","author":"Peters","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/131.1.243","article-title":"Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation","volume":"131","author":"Peters","year":"1979","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2025.110822_b0085","doi-asserted-by":"crossref","unstructured":"Kal HB, Loes van Kempen-Harteveld M, Heijenbrok-Kal MH, Struikmans H. Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]. 2006;182:672-9.","DOI":"10.1007\/s00066-006-1528-6"},{"key":"10.1016\/j.radonc.2025.110822_b0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0167-8140(85)80122-5","article-title":"Effect of dose-rate on total body irradiation: lethality and pathologic findings","volume":"4","author":"Travis","year":"1985","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-8140(90)90161-O","article-title":"Radiobiological aspects of continuous low dose-rate irradiation and fractionated high dose-rate irradiation","volume":"19","author":"Turesson","year":"1990","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0360-3016(88)90307-0","article-title":"Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size, and fractionation interval on acute and delayed toxicity","volume":"15","author":"Deeg","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0360-3016(87)90046-0","article-title":"Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man","volume":"13","author":"Tarbell","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0110","doi-asserted-by":"crossref","unstructured":"O'Donoghue JA. Fractionated versus low dose-rate total body irradiation. Radiobiological considerations in the selection of regimes. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 1986;7:241-7.","DOI":"10.1016\/S0167-8140(86)80035-4"},{"key":"10.1016\/j.radonc.2025.110822_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0360-3016(86)90417-7","article-title":"Effect of X-irradiation dose rate on the clonagenic survival of human and experimental animal hematopoietic tumor cell lines: evidence for heterogeneity","volume":"12","author":"FitzGerald","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood.V77.3.661.661","article-title":"Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation","volume":"77","author":"Down","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.110822_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073745","article-title":"Effect of radiation dose-rate on hematopoietic cell engraftment in adult zebrafish","volume":"8","author":"Glass","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2025.110822_b0130","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/09553009314552011","article-title":"Compromising effect of low dose-rate total body irradiation on allogeneic bone marrow engraftment","volume":"64","author":"van Os","year":"1993","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2025.110822_b0135","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1118\/1.3462971","article-title":"QA for helical tomotherapy: report of the AAPM Task Group 148","volume":"37","author":"Langen","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phro.2017.11.002","article-title":"Volumetric modulated arc therapy based total body irradiation: Workflow and clinical experience with an indexed rotational immobilization system","volume":"4","author":"Ouyang","year":"2017","journal-title":"Phys Imag Radiat Onc"},{"key":"10.1016\/j.radonc.2025.110822_b0145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13014-019-1296-y","article-title":"Effect of changes in monitor unit rate and energy on dose rate of total marrow irradiation based on Linac volumetric arc therapy","volume":"14","author":"Son","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.radonc.2018.08.005","article-title":"Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability","volume":"129","author":"Tas","year":"2018","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0155","article-title":"Acute toxicity of total body irradiation using volumetric arc therapy with a focus on the effect of lung dose rate","volume":"9","author":"Melton","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.785916","article-title":"Optimized conformal total body irradiation among recipients of TCRalphabeta\/CD19-depleted grafts in pediatric patients with hematologic malignancies: single-center experience","volume":"11","author":"Kobyzeva","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0165","doi-asserted-by":"crossref","unstructured":"Shinde A, Wong J. Acute and late toxicities with total marrow irradiation. In: Wong J, Hui SK, editors. Total Marrow Irradiation. 1st ed. New York, NY: Springer Nature; 2020. p. 187-96.","DOI":"10.1007\/978-3-030-38692-4_14"},{"key":"10.1016\/j.radonc.2025.110822_b0170","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/S1470-2045(20)30342-9","article-title":"Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia","volume":"21","author":"Wong","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/acm2.12742","article-title":"Organ sparing of linac-based targeted marrow irradiation over total body irradiation","volume":"20","author":"Warrell","year":"2019","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.13675","article-title":"Organ sparing total marrow irradiation compared to total body irradiation prior to allogeneic stem cell transplantation","volume":"107","author":"Haraldsson","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.radonc.2025.110822_b0185","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJM197504242921706","article-title":"Bone-marrow transplantation (second of two parts)","volume":"292","author":"Thomas","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.110822_b0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0167-8140(90)90179-Z","article-title":"Clinical basis for TBI fractionation","volume":"18","author":"Cosset","year":"1990","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0195","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2307\/3577994","article-title":"Radiation sensitivity of the hemopoietic stem cell","volume":"128","author":"van Bekkum","year":"1991","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2025.110822_b0200","first-page":"1431","article-title":"Radiation damage repair capacity of primary clonogenic blasts in acute lymphoblastic leukemia","volume":"53","author":"Uckun","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2025.110822_b0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0167-8140(00)00255-3","article-title":"Radiobiological modelling of the treatment of leukaemia by total body irradiation","volume":"58","author":"Wheldon","year":"2001","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0609.1994.tb00194.x","article-title":"Heterogeneous X-ray survival characteristics of lymphocytes in prolymphocytic leukaemia: mathematical analysis distinguishing delayed cell death and true radioresistance","volume":"53","author":"Thomson","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.radonc.2025.110822_b0215","doi-asserted-by":"crossref","unstructured":"Dubray B, Giraud P, Helfre S, Dendale R, Cosset JM. [Biological basis of total body irradiation]. Cancer Radiother. 1999;3:154-61.","DOI":"10.1016\/S1278-3218(99)80046-8"},{"key":"10.1016\/j.radonc.2025.110822_b0220","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2025.110822_b0225","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1200\/JCO.21.01755","article-title":"Naive T-cell depletion to prevent chronic graft-versus-host disease","volume":"40","author":"Bleakley","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.2023021336","article-title":"TCR\u03b1\u03b2\/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis","volume":"143","author":"Merli","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.110822_b0235","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0360-3016(89)90150-8","article-title":"Radiobiological features of human pluripotent bone marrow progenitor cells (CFU-GEMM)","volume":"17","author":"Uckun","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0240","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0360-3016(85)90315-3","article-title":"Radiation response of human normal and leukemic hemopoietic cells assayed by in vitro colony formation","volume":"11","author":"Kimler","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0245","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1667\/RR15087.1","article-title":"Effects of low-to-moderate doses of gamma radiation on mouse hematopoietic system","volume":"190","author":"Li","year":"2018","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2025.110822_b0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2021.02.029","article-title":"Hematological toxicity in patients with solid malignant tumors treated with radiation - temporal analysis, dose response and impact on survival","volume":"158","author":"Terrones-Campos","year":"2021","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0255","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/0360-3016(83)90413-3","article-title":"Cell survival kinetics in peripheral blood and bone marrow during total body irradiation for marrow transplantation","volume":"9","author":"Shank","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0260","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/bjc.1990.180","article-title":"Similar effects on murine haemopoietic compartment of low dose rate single dose and high dose rate fractionated total body irradiation. preliminary results after a unique dose of 750 cGy","volume":"61","author":"Girinski","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2025.110822_b0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0167-8140(87)80197-4","article-title":"Total body irradiation\u2013review of treatment techniques in Europe","volume":"9","author":"Quast","year":"1987","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2141.1989.tb00254.x","article-title":"The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation","volume":"73","author":"Frassoni","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.radonc.2025.110822_b0275","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0360-3016(89)90105-3","article-title":"Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse","volume":"17","author":"Scarpati","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0280","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0360-3016(92)90909-2","article-title":"Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide\u2013a phase I trial","volume":"23","author":"Petersen","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0285","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0290","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2005.02.032","article-title":"Dose response and factors related to interstitial pneumonitis after bone marrow transplant","volume":"63","author":"Sampath","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0295","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.110822_b0300","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.110822_b0305","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1200\/JCO.2000.18.2.348","article-title":"New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia","volume":"18","author":"Socie","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0310","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.2018874115","article-title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","volume":"133","author":"Baker","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.110822_b0315","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0936-6555(05)80695-8","article-title":"Fractionated total body irradiation: some radiobiological considerations","volume":"5","author":"Muller-Runkel","year":"1993","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2025.110822_b0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1259\/0007-1285-60-711-279","article-title":"The implications of in-vitro radiation-survival curves for the optimal scheduling of total-body irradiation with bone marrow rescue in the treatment of leukaemia","volume":"60","author":"O'Donoghue","year":"1987","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.110822_b0325","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijrobp.2018.06.015","article-title":"Single-dose daily fractionation is not inferior to twice-a-day fractionated total-body irradiation before allogeneic stem cell transplantation for acute leukemia: a useful practice simplification resulting from the SARASIN study","volume":"102","author":"Belkacemi","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0330","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41409-019-0470-z","article-title":"Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation","volume":"54","author":"Sengelov","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0335","doi-asserted-by":"crossref","unstructured":"Hoeben BAW, Pazos M, Albert MH, Seravalli E, Bosman ME, Losert C, et al. Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working group. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2021;155:113-9.","DOI":"10.1016\/j.radonc.2020.10.032"},{"key":"10.1016\/j.radonc.2025.110822_b0340","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijrobp.2021.07.1715","article-title":"Practice patterns of pediatric total body irradiation techniques: a children's oncology group survey","volume":"111","author":"Rassiah","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0345","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbmt.2017.04.002","article-title":"Dose escalation of total marrow irradiation in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Hui","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0350","doi-asserted-by":"crossref","first-page":"2 -","DOI":"10.1182\/blood-2020-139282","article-title":"Total body irradiation among recipients of Tcr\u03b1\u03b2 \/CD19- depleted grafts in a cohort of children with hematologic malignances: single center experience","volume":"136","author":"Kobyzeva","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.110822_b0355","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.radonc.2011.01.016","article-title":"Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant","volume":"98","author":"Corvo","year":"2011","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1035375","article-title":"Impact of total marrow\/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies","volume":"12","author":"Saldi","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0365","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2022.09.069","article-title":"Phase 1 study of the combination of escalated total marrow irradiation using helical tomotherapy and fixed high-dose melphalan (140 mg\/m(2)) followed by autologous stem cell transplantation at first relapse in multiple myeloma","volume":"115","author":"Cailleteau","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0370","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2012.03.033","article-title":"Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"85","author":"Wong","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0375","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijrobp.2005.06.020","article-title":"Evidence for predictive validity of blood assays to evaluate individual radiosensitivity","volume":"64","author":"Severin","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0380","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3324\/haematol.2015.132860","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation","volume":"101","author":"Storb","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.radonc.2025.110822_b0385","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0360-3016(95)00115-F","article-title":"Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a phase I\/II trial","volume":"32","author":"Demirer","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0390","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0360-3016(89)90446-X","article-title":"Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant","volume":"17","author":"Lawton","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0395","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtct.2023.04.014","article-title":"Total marrow irradiation for second allogeneic hematopoietic stem cell transplantation in patients with advanced acute leukemia","volume":"29","author":"Dominietto","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.radonc.2025.110822_b0400","first-page":"42","article-title":"The safety and efficacy of a novel hypo-fractionated total marrow and lymphoid irradiation before allogeneic stem cell transplantation for lymphoma and acute leukemia","volume":"26","author":"Shi","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0405","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/cas.15611","article-title":"Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia","volume":"114","author":"Ogawa","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2025.110822_b0410","doi-asserted-by":"crossref","first-page":"S544","DOI":"10.1016\/j.ijrobp.2004.07.512","article-title":"Normal tissue sparing in total marrow and total lymphatic irradiation with helical tomotherapy","volume":"60","author":"Schultheiss","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0415","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1003908","article-title":"Total marrow irradiation (TMI): addressing an unmet need in hematopoietic cell transplantation - a single institution experience review","volume":"12","author":"Wong","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.774348","article-title":"Total body irradiation in haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia: review of the literature and future directions","volume":"9","author":"Hoeben","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.radonc.2025.110822_b0430","doi-asserted-by":"crossref","unstructured":"Aristei C, Saldi S, Pierini A, Ruggeri L, Piccine S, Ingrosso G, et al. Total marrow\/lymphoid irradiation in the conditioning regimen for haploidentical T-cell depleted hematopoietic stem cell transplantation for acute myeloid leukemia. The Perugia experience. In: Wong J, Hui SK, editors. Total Marrow Irradiation. 1st ed. New York, NY: Springer Nature; 2020. p. 111-22.","DOI":"10.1007\/978-3-030-38692-4_7"},{"key":"10.1016\/j.radonc.2025.110822_b0435","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1182\/blood.V106.11.1176.1176","article-title":"Total Marrow Irradiation (TMI) with helical tomotherapy and PBPC following high-dose melphalan and PBPC as part of tandem therapy for patients with multiple myeloma","volume":"106","author":"Somlo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.110822_b0440","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s41409-020-01181-x","article-title":"Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma","volume":"56","author":"Giebel","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0445","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.bbmt.2014.09.005","article-title":"Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine\/busulfan: a phase I study","volume":"20","author":"Patel","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0450","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/bloodadvances.2022007530","article-title":"A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT","volume":"7","author":"Tran","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.radonc.2025.110822_b0455","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbmt.2017.09.019","article-title":"Total marrow lymphoid irradiation\/fludarabine\/ melphalan conditioning for allogeneic hematopoietic cell transplantation","volume":"24","author":"Jensen","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0460","doi-asserted-by":"crossref","unstructured":"Stein AS, Al Malki MM, Yang D, Palmer JM, Tsai NC, Aldoss I, et al. Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission. Transplantation and cellular therapy. 2022;28:368.e1-.e7.","DOI":"10.1016\/j.jtct.2022.03.025"},{"key":"10.1016\/j.radonc.2025.110822_b0465","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijrobp.2019.08.010","article-title":"Radiation-related toxicities using organ sparing total marrow irradiation transplant conditioning regimens","volume":"105","author":"Shinde","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0470","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.radonc.2017.07.018","article-title":"Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents","volume":"124","author":"Hui","year":"2017","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0475","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2022.05.027","article-title":"ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children","volume":"173","author":"Hoeben","year":"2022","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0480","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2014.01.036","article-title":"Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0485","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.970425","article-title":"Auto-segmentation for total marrow irradiation","volume":"12","author":"Watkins","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0490","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11547-024-01760-8","article-title":"Deep learning and atlas-based models to streamline the segmentation workflow of total marrow and lymphoid irradiation","volume":"129","author":"Dei","year":"2024","journal-title":"Radiol Med"},{"key":"10.1016\/j.radonc.2025.110822_b0495","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2018.04.016","article-title":"SIOPE - brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy","volume":"128","author":"Ajithkumar","year":"2018","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0500","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2020.05.038","article-title":"Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines","volume":"150","author":"Mir","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0505","first-page":"28","article-title":"Influence of eye movement on lens dose and optic nerve target coverage during craniospinal irradiation","volume":"31","author":"Hoeben","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0510","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.924961","article-title":"Impact of respiratory motion on lung dose during total marrow irradiation","volume":"12","author":"Kavak","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0515","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijrobp.2019.02.034","article-title":"Higher reported lung dose received during total body irradiation for allogeneic hematopoietic stem cell transplantation in children with acute lymphoblastic leukemia is associated with inferior survival: a report from the Children's Oncology Group","volume":"104","author":"Esiashvili","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0520","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ijrobp.2007.12.009","article-title":"Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation","volume":"71","author":"Cheng","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0525","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","article-title":"Chronic kidney disease after hematopoietic cell transplantation: a systematic review","volume":"8","author":"Ellis","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0530","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2006.02.021","article-title":"Renal dysfunction after total body irradiation: dose-effect relationship","volume":"65","author":"Kal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0535","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.bmt.1701022","article-title":"Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation","volume":"20","author":"Lawton","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0540","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.radonc.2011.06.005","article-title":"Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation","volume":"102","author":"Han","year":"2012","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0545","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/BF02011826","article-title":"MRI \u201croad-map\u201d of normal age-related bone marrow","volume":"25","author":"Taccone","year":"1995","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.radonc.2025.110822_b0550","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3857\/roj.2020.00528","article-title":"Total marrow and lymphoid irradiation with helical tomotherapy: a practical implementation report","volume":"38","author":"Chilukuri","year":"2020","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2025.110822_b0555","article-title":"Target coverage and normal organ sparing in dose-escalated total marrow and lymphatic irradiation: a single-institution experience","volume":"12","author":"Han","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0560","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/S1470-2045(19)30034-8","article-title":"Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group","volume":"20","author":"Hoeben","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0565","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2319\/020309-67.1","article-title":"Mandibular growth, remodeling, and maturation during infancy and early childhood","volume":"80","author":"Liu","year":"2010","journal-title":"Angle Orthod"},{"key":"10.1016\/j.radonc.2025.110822_b0570","doi-asserted-by":"crossref","unstructured":"Gregoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2014;110:172-81.","DOI":"10.1016\/j.radonc.2013.10.010"},{"key":"10.1016\/j.radonc.2025.110822_b0575","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0580","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prro.2012.01.007","article-title":"Computed tomographic atlas for the new international lymph node map for lung cancer: a radiation oncologist perspective","volume":"3","author":"Lynch","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0585","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ijrobp.2005.05.062","article-title":"Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy","volume":"63","author":"Taylor","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110822_b0590","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2020.05.018","article-title":"Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation","volume":"149","author":"Garda","year":"2020","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051536","article-title":"Internal guidelines for reducing lymph node contour variability in total marrow and lymph node irradiation","volume":"15","author":"Dei","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.110822_b0600","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa050642","article-title":"Protective conditioning for acute graft-versus-host disease","volume":"353","author":"Lowsky","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.110822_b0605","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood.V55.2.344.344","article-title":"Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia","volume":"55","author":"Ramsay","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.110822_b0610","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3857\/roj.2012.30.4.165","article-title":"Total lymphoid irradiation based conditioning for hematopoietic stem cell transplantation in severe aplastic anemia","volume":"30","author":"Lee","year":"2012","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2025.110822_b0615","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-3046.2011.01542.x","article-title":"Favorable preliminary results using TLI\/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia","volume":"15","author":"Pillai","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0620","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41409-022-01883-4","article-title":"Second allogeneic hematopoietic stem cell transplantation in patients with inborn errors of immunity","volume":"58","author":"Laberko","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2025.110822_b0625","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0025-6196(12)60804-0","article-title":"Total lymphoid irradiation: a novel and successful therapy for resistant cardiac allograft rejection","volume":"67","author":"Evans","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.radonc.2025.110822_b0630","article-title":"A single institution experience of total lymphoid irradiation using helical tomotherapy as part of the conditioning regimen of transplantation for severe aplastic anemia patients","volume":"4","author":"Lee","year":"2020","journal-title":"Therap Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0635","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s12094-019-02205-9","article-title":"TLI in pediatric patients","volume":"22","author":"Ocanto","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2025.110822_b0640","first-page":"772","article-title":"Evolution of dosimetric treatment planning for pediatric total lymphoid irradiation (TLI): a single-institution experience","volume":"28","author":"Ferrer","year":"2023","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.radonc.2025.110822_b0645","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2020.09.033","article-title":"Radiotherapy Treatment plannINg study Guidelines (RATING): a framework for setting up and reporting on scientific treatment planning studies","volume":"153","author":"Hansen","year":"2020","journal-title":"Radiother Oncol : J Eur Soc Therap Radiol Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:43:22Z","timestamp":1777553002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":129,"alternative-id":["S0167814025001173"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110822","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale, implementation considerations, delineation and planning target objective recommendations for volumetric modulated arc therapy and helical tomotherapy total body irradiation, total marrow irradiation, total marrow and lymphoid irradiation and total lymphoid irradiation","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110822"}}